VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CANF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CANFCan-Fite BioPharma Ltd.
$1.81$2M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCANFQuarterly Balance Sheet

Can-Fite BioPharma Ltd. (CANF) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Can-Fite BioPharma Ltd. (CANF) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

CANF Balance Sheet

Quarterly statement

CANF Balance Sheet

Can-Fite BioPharma Ltd. (CANF) balance sheet — 15-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets8M8M9.44M9.44M7.62M7.62M8.98M8.98M5.83M5.83M9.91M9.06M10.91M13.38M9.16M12.56M14.59M17.67M20.07M14.47M
Cash & Short-Term Investments7.04M7.04M8.54M8.54M6.46M6.46M7.89M7.89M4.73M4.73M8.92M7.94M9.62M12.42M7.99M10.81M12.77M16.7M19.14M13.66M
Cash Only2.98M2.98M5.53M5.53M6.45M6.45M4.83M4.83M4.72M4.72M4.28M3.38M3.46M1.26M2.98M3.73M1.71M5.5M4.39M5.81M
Short-Term Investments4.06M4.06M3.01M3.01M2K2K3.06M3.06M9K9K4.64M4.56M6.16M11.15M5.01M7.09M11.05M11.2M14.75M7.86M
Accounts Receivable0000000000000047K00048K811K
Days Sales Outstanding--------------21.95---193.7468.43
Inventory0000000000000000000-811K
Days Inventory Outstanding--------------------
Other Current Assets0074K74K001.09M77K0078K1.12M1.29M0000000
Total Non-Current Assets52K52K74K74K96K96K138K138K94K94K81K105K123K110K126K141K157K174K185K165K
Property, Plant & Equipment52K52K74K74K96K96K138K138K94K94K81K105K123K110K126K141K157K174K185K165K
Fixed Asset Turnover1.94x1.60x1.37x1.19x1.05x0.86x1.30x1.54x1.68x1.81x1.67x1.72x1.68x1.66x1.48x1.37x1.23x1.14x1.17x1.72x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets00000000000-105K-123K-110K-126K-141K-157K000
Total Assets8.05M8.05M9.51M9.51M7.72M7.72M9.12M9.12M5.92M5.92M9.99M9.17M11.03M13.49M9.28M12.71M14.75M17.85M20.25M14.64M
Asset Turnover0.01x0.01x0.01x0.01x0.01x0.01x0.02x0.02x0.03x0.02x0.02x0.02x0.02x0.02x0.02x0.01x0.01x0.01x0.01x0.02x
Asset Growth %4.34%4.34%4.32%4.32%30.36%30.36%-8.7%-0.53%-46.32%-56.1%7.61%-27.84%-25.19%-24.42%-54.16%-13.2%52.33%40.06%112.67%9.85%
Total Current Liabilities2.23M2.23M2.73M2.73M2.12M2.12M2.05M2.05M1.99M1.99M2.02M2.21M2.23M2.89M2.5M2.8M2.15M2.9M2.73M2.15M
Accounts Payable681K681K1.16M1.16M1.15M1.15M618K618K885K885K427K647K810K963K896K1.47M824K1.12M954K806K
Days Payables Outstanding--------------------
Short-Term Debt00000000000000000000
Deferred Revenue (Current)00405K0405K0405K0636K0622K783K783K783K783K818K818K818K818K1M
Other Current Liabilities405K405K811K405K0405K675K405K0636K694K000492K000603K0
Current Ratio3.60x3.60x3.46x3.46x3.60x3.60x4.38x4.38x2.93x2.93x4.90x4.10x4.89x4.63x3.66x4.49x6.78x6.09x7.35x6.72x
Quick Ratio3.60x3.60x3.46x3.46x3.60x3.60x4.38x4.38x2.93x2.93x4.90x4.10x4.89x4.63x3.66x4.49x6.78x6.09x7.35x7.10x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities975K975K1.19M1.19M1.42M1.42M1.63M1.63M1.46M1.46M1.73M1.72M1.93M2.1M2.31M2.48M2.7M2.92M3.14M3.15M
Long-Term Debt00000000000000000000
Capital Lease Obligations1K1K15K15K33K33K51K51K21K21K13K17K22K6K14K26K40K54K71K62K
Deferred Tax Liabilities00000000000-1.71M-1.9M-2.1M-2.29M-2.46M-2.66M-2.87M-3.07M-3.09M
Other Non-Current Liabilities974K974K01.18M01.38M01.58M01.44M0000000000
Total Liabilities3.2M3.2M3.92M3.92M3.54M3.54M3.68M3.68M3.44M3.44M3.75M3.93M4.16M5M4.81M5.28M4.85M5.82M5.87M5.3M
Total Debt49K49K71K71K90K90K104K104K57K57K40K51K66K48K62K74K87K109K124K102K
Net Debt-2.94M-2.94M-5.46M-5.46M-6.36M-6.36M-4.72M-4.72M-4.66M-4.66M-4.24M-3.33M-3.39M-1.22M-2.92M-3.65M-1.63M-5.39M-4.27M-5.7M
Debt / Equity0.01x0.01x0.01x0.01x0.02x0.02x0.02x0.02x0.02x0.02x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x0.01x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-----------131.00x-621.67x---192.69x--17.11x-37.03x-12.79x-
Total Equity4.86M4.86M5.59M5.59M4.18M4.18M5.44M5.44M2.48M2.48M6.24M5.24M6.87M8.49M4.47M7.43M9.89M12.02M14.38M9.33M
Equity Growth %16.04%16.04%2.87%2.87%68.78%68.78%-12.93%3.84%-63.94%-70.81%39.6%-29.52%-30.51%-29.37%-68.91%-20.42%150.11%69.88%136.78%-2.17%
Book Value per Share1.311.310.022.590.370.370.640.640.410.411.261.281.682.161.642.733.644.426.495.11
Total Shareholders' Equity4.86M4.86M5.59M5.59M4.18M4.18M5.44M5.44M2.48M2.48M6.24M5.24M6.87M8.49M4.47M7.43M9.89M12.02M14.38M9.33M
Common Stock00000000000000060.65M60.65M60.65M60.65M43.72M
Retained Earnings-180.79M-180.79M-176.19M-176.19M-171.24M-171.24M-166.36M-166.36M-162.44M-162.44M-158.48M-156.83M-155.07M-153.4M-150.85M-147.83M-145.3M-143.11M-140.67M-133.97M
Treasury Stock00000000000000000000
Accumulated OCI1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M1.13M
Minority Interest00000000000000000000